ChemSpider 2D Image | Fesoterodine Fumarate | C30H41NO7

Fesoterodine Fumarate

  • Molecular FormulaC30H41NO7
  • Average mass527.649 Da
  • Monoisotopic mass527.288330 Da
  • ChemSpider ID8025521

  • Double-bond stereo - Double-bond stereo

    defined stereocentres - 1 of 1 defined stereocentres

More details:

Validated by Experts, Validated by Users, Non-Validated, Removed by Users

(2E)-2-Butendisäure --2-[(1R)-3-(diisopropylamino)-1-phenylpropyl]-4-(hydroxymethyl)phenyl-2-methylpropanoat (1:1) [German] [ACD/IUPAC Name]
(R)-2-(3-(Diisopropylamino)-1-phenylpropyl)-4-(hydroxymethyl)phenyl isobutyrate fumarate
(R)-Fesoterodine fumarate
2-[(1R)-3-(Diisopropylamino)-1-phenylpropyl]-4-(hydroxymethyl)phenyl 2-methylpropanoate (2E)-2-butenedioate (1:1) [ACD/IUPAC Name]
286930-03-8 [RN]
Acide (2E)-2-butènedioïque - 2-méthylpropanoate de 2-[(1R)-3-(diisopropylamino)-1-phénylpropyl]-4-(hydroxyméthyl)phényle (1:1) [French] [ACD/IUPAC Name]
EOS72165S7
Fesoterodine Fumarate [USAN]
Propanoic acid, 2-methyl-, 2-[(1R)-3-[bis(1-methylethyl)amino]-1-phenylpropyl]-4-(hydroxymethyl)phenyl ester, (2E)-2-butenedioate (1:1) [ACD/Index Name]
Toviaz [Trade name]
More...

Validated by Experts, Validated by Users, Non-Validated, Removed by Users

SMP 8272 [DBID]
SPM 907 [DBID]
SPM-8272 [DBID]
SPM-907 [DBID]
  • Experimental Physico-chemical Properties
  • Miscellaneous

    • Bio Activity:

      Fesoterodine Fumarate is an antimuscarinic agent and is rapidly de-esterified to its active metabolite 5-hydroxymethyl tolterodine that is a muscarinic receptor antagonist.; IC50 value:; Target: mAChR; Fesoterodine has the advantage of allowing more flexible dosage than other muscarinic antagonists. MedChem Express HY-A0030
      Fesoterodine Fumarate is an antimuscarinic agent and is rapidly de-esterified to its active metabolite 5-hydroxymethyl tolterodine that is a muscarinic receptor antagonist.;IC50 value:;Target: mAChRFesoterodine has the advantage of allowing more flexible dosage than other muscarinic antagonists. Its tolerability and side effects are similar to other muscarinic antagonists and as a new drug seems unlikely to make great changes in practices of treatment for overactive bladder. MedChem Express HY-A0030
      GPCR/G protein MedChem Express HY-A0030
      GPCR/G protein; Neuronal Signaling; MedChem Express HY-A0030
      mAChR MedChem Express HY-A0030

Predicted data is generated using the ACD/Labs Percepta Platform - PhysChem Module, version: 14.00

No predicted properties have been calculated for this compound.

Click to predict properties on the Chemicalize site


Advertisement